Efficacy and safety of semaglutide injection in Indian patients with type 2 diabetes mellitus inadequately controlled on metformin: a phase 3, randomized, active-controlled trial (SIZE-DM study)

Nitin Kapoor, Shehla Shaikh, Saptarshi Bhattacharya, Sanjay Kalra, Sambit Das, Sunil Kota, Vipul Khandelwal, Arindam Naskar, Amol Dange, Sanket Sorate, Mayura Choudhari, Narayan Deogaonkar, Jayashree Shembalkar, Deepak Varade, Shejole Vivek Samadhan, Shrikant Somani, Richa Giri, Jasminder Singh, Rajesh Kumar Palaparthi, Narendra Prasad, Paramesh Shamanna, Santosh Saklecha, Kushal Bangar, Aruna Mangipudi, Mayur Mayabhate, Nitin Kapure, Akhilesh Sharma, Radhakrishna Vaddem, Mukesh Jaiswal

Open source

DOI: 10.1186/s40842-026-00290-8
Published: 2026-04-24
Container: Cardiovascular Diabetology – Endocrinology Reports
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s40842-026-00290-8,
  title = {Efficacy and safety of semaglutide injection in Indian patients with type 2 diabetes mellitus inadequately controlled on metformin: a phase 3, randomized, active-controlled trial (SIZE-DM study)},
  author = {Nitin Kapoor and Shehla Shaikh and Saptarshi Bhattacharya and Sanjay Kalra and Sambit Das and Sunil Kota and Vipul Khandelwal and Arindam Naskar and Amol Dange and Sanket Sorate and Mayura Choudhari and Narayan Deogaonkar and Jayashree Shembalkar and Deepak Varade and Shejole Vivek Samadhan and Shrikant Somani and Richa Giri and Jasminder Singh and Rajesh Kumar Palaparthi and Narendra Prasad and Paramesh Shamanna and Santosh Saklecha and Kushal Bangar and Aruna Mangipudi and Mayur Mayabhate and Nitin Kapure and Akhilesh Sharma and Radhakrishna Vaddem and Mukesh Jaiswal},
  year = {2026},
  journal = {Cardiovascular Diabetology – Endocrinology Reports},
  doi = {10.1186/s40842-026-00290-8},
  url = {https://doi.org/10.1186/s40842-026-00290-8}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of semaglutide injection in Indian patients with type 2 diabetes mellitus inadequately controlled on metformin: a phase 3, randomized, active-controlled trial (SIZE-DM study)
AU  - Nitin Kapoor
AU  - Shehla Shaikh
AU  - Saptarshi Bhattacharya
AU  - Sanjay Kalra
AU  - Sambit Das
AU  - Sunil Kota
AU  - Vipul Khandelwal
AU  - Arindam Naskar
AU  - Amol Dange
AU  - Sanket Sorate
AU  - Mayura Choudhari
AU  - Narayan Deogaonkar
AU  - Jayashree Shembalkar
AU  - Deepak Varade
AU  - Shejole Vivek Samadhan
AU  - Shrikant Somani
AU  - Richa Giri
AU  - Jasminder Singh
AU  - Rajesh Kumar Palaparthi
AU  - Narendra Prasad
AU  - Paramesh Shamanna
AU  - Santosh Saklecha
AU  - Kushal Bangar
AU  - Aruna Mangipudi
AU  - Mayur Mayabhate
AU  - Nitin Kapure
AU  - Akhilesh Sharma
AU  - Radhakrishna Vaddem
AU  - Mukesh Jaiswal
PY  - 2026
JO  - Cardiovascular Diabetology – Endocrinology Reports
DO  - 10.1186/s40842-026-00290-8
UR  - https://doi.org/10.1186/s40842-026-00290-8
ER  -

APA

Kapoor, N., Shaikh, S., Bhattacharya, S., Kalra, S., Das, S., Kota, S., Khandelwal, V., Naskar, A., Dange, A., Sorate, S., Choudhari, M., Deogaonkar, N., Shembalkar, J., Varade, D., Samadhan, S. V., Somani, S., Giri, R., Singh, J., Palaparthi, R. K., Prasad, N., Shamanna, P., Saklecha, S., Bangar, K., Mangipudi, A., Mayabhate, M., Kapure, N., Sharma, A., Vaddem, R., & Jaiswal, M. (2026). Efficacy and safety of semaglutide injection in Indian patients with type 2 diabetes mellitus inadequately controlled on metformin: a phase 3, randomized, active-controlled trial (SIZE-DM study). Cardiovascular Diabetology – Endocrinology Reports. https://doi.org/10.1186/s40842-026-00290-8

Source records

crossref · retrieved 2026-09-26T07:43:52.723Z